Single-agent paclitaxel in patients with metastatic breast cancer receiving high-dose chemotherapy with peripheral blood stem cell support. [electronic resource]
Producer: 19990415Description: 162-7 p. digitalISSN:- 0277-3732
- Adult
- Anthracyclines -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Carboplatin -- administration & dosage
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Middle Aged
- Neoplasm Metastasis
- Paclitaxel -- administration & dosage
- Proportional Hazards Models
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.